World Health Organization (WHO) has urged countries to increase the production of dexamethasone, which has shown to be an effective medication in reducing COVID-19 deaths among severely ill patients. This was stated by WHO President Tedros Adhanom Ghebreyesus, BBC reports.
He said demand for the drug had surged after researchers at Oxford University published a study on the benefits of its use.
“Although the data are still preliminary, the recent finding that the steroid dexamethasone has life-saving potential for critically ill COVID-19 patients gave us a much-needed reason to celebrate," Ghebreyesus stated.
He also noted that the next challenge was to increase production and rapidly and equitably distribute dexamethasone worldwide, focusing on where it was needed most.
As we reported earlier, Israel is expected to receive the first vaccines against coronavirus in December.
"Moderna biotechnology company was one of the first to announce the completion of a vaccine development supported by the Institute of Infectious Diseases of the USA. 45 American volunteers have already been vaccinated, and the drug’s safety test was successful," the report said.